A new system to help doctors make better decisions for asthma treatment
Official title: TIBSA: A tailored interoperable guideline-based clinical decision-support system for asthma
Funded at Elimu Informatics, INC. · NIH-10919374 · Data updated 2026-11-12
This study is creating a helpful app for doctors to better manage asthma by using the latest treatment guidelines and collecting information from patients, so everyone can work together to choose the best care for asthma.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Elimu Informatics, INC. NIH-funded |
| Lab location | 1 site (El Cerrito, UNITED STATES) |
| Project start | September 20, 2024 |
| Project end | September 19, 2025 |
| Funding year | 2024 |
| Award (this year) | $353,403 |
| NIH project number | 1R43HL174218-01 |
| Project ID | NIH-10919374 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are managing asthma.
✕Less likely to help
Patients with asthma who are not engaged in shared decision-making or those who do not have access to the necessary technology may not benefit from this research.
What this research studies
This research focuses on developing a clinical decision-support system specifically designed for asthma management. It aims to integrate the latest asthma treatment guidelines into a user-friendly application that assists healthcare providers in making informed decisions during patient visits. By collecting data directly from patients, the system promotes shared decision-making between patients and their doctors, ensuring that treatment options align with the most current recommendations. The goal is to improve the quality of care for asthma patients and enhance their overall health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved asthma management and reduced emergency department visits for patients.
How similar studies have gone: Previous interventions using similar decision-support systems have shown positive outcomes in patient satisfaction and quality of care.
Where this research is happening
-
Elimu Informatics, INC.
El Cerrito, United States Active
Researchers
- Principal investigator: Boxwala, Aziz a — Elimu Informatics, INC.
- Study coordinator: Boxwala, Aziz a
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.